Table 3.
Bivariate and multivariate analysis for factors associated to ARs after vaccination against SARS-CoV-2 (first dose and second dose).
| Dose | Any Sign or Symptom | Any Local Sign or Symptom | Any Systemic Sign or Symptom | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| cOR | 95% CI | aOR | 95% CI | cOR | 95% CI | aOR | 95% CI | cOR | 95% CI | aOR | 95% CI | ||
| First | Female (vs. Male) | 1.57 | 0.99–2.49 | - | - | 1.55 | 0.98–2.47 | - | - | 1.99 | 1.11–3.57 | - | - |
| Age 31–45 (vs. > 45 years) | 1.81 | 1.02–3.22 | - | - | 1.53 | 0.86–2.71 | - | - | 1.82 | 0.90–3.70 | - | - | |
| Age < 31 (vs. > 45 years) | 2.66 | 1.5–4.7 | - | - | 2.66 | 1.50–4.71 | - | - | 1.66 | 0.82–3.35 | - | - | |
| Healthcare worker (vs. No Healthcare worker) | 1.41 | 0.85–2.35 | - | - | 1.32 | 0.80–2.20 | - | - | 0.96 | 0.52–1.76 | - | - | |
| Distance between the first and the second dose (for day increase) | 1.16 | 0.70–1.90 | - | - | 1.14 | 0.70–1.88 | - | - | 0.99 | 0.54–1.80 | - | - | |
| Second | Female (vs. Male) | 2.09 | 1.16–3.76 | 1.81 | 0.97–3.35 | 1.81 | 1.06–3.09 | 1.57 | 0.90–2.74 | 1.96 | 1.18–3.26 | 1.79 | 1.06–3.02 |
| Age 31–45 (vs. > 45 years) | 2.15 | 1.11–4.15 | 1.92 | 0.98–3.78 | 2.15 | 1.15–4.01 | 1.98 | 1.05–3.73 | 1.68 | 0.93–3.05 | 1.51 | 0.82–2.76 | |
| Age < 31 (vs. > 45 years) | 8.07 | 3.20–20.32 | 7.47 | 2.95–18.91 | 4.89 | 2.37–10.08 | 4.59 | 2.21–9.52 | 3.54 | 1.84–6.81 | 3.27 | 1.68–6.34 | |
| Healthcare worker (vs. No Healthcare worker) | 1.25 | 0.67–2.31 | - | - | 1.05 | 0.59–1.87 | - | - | 1.06 | 0.61–1.84 | - | - | |
| Distance between the first and the second dose (for day increase) | 1.34 | 0.73–2.45 | - | - | 1.39 | 0.80–2.42 | - | - | 1.35 | 0.80–2.29 | - | - | |
cOR = crude Odds ratio. aOR = Adjusted Odds Ratio.